EOE.Dupixent is also used foreosinophilic esophagitis(EOE) in adults and children 1 year of age and older, who weigh at least 33 pounds (15 kg). Prurigo nodularisin adults. Dupixent cost The cost of Dupixent varies based on your insurance coverage, including type of prescription drug insurance...
dependent asthma; as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP), and for the treatment of adult and pediatric patients aged 12 years and older, weighing at least 40 kg, with eosinophilic esophagitis (EoE). ...
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application for Dupixent® to treat children aged 1 to 11 years with eosinophilic esopha
asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), eosinophilic esophagitis (EoE), prurigo nodularis, chronic spontaneous urticaria (CSU) and chronic obstructive pulmonary disease (COPD) in different age populations. More than 1,000,000...
to treat adults and children 1 year of age and older with eosinophilic esophagitis (EoE), who weigh at least 33 pounds (15 kg). It is not known if DUPIXENT is safe and effective in children with eosinophilic esophagitis under 1 year of age, or who weigh less than 33 poun...
Patients 12 years of age and older with eosinophilic esophagitis (EoE) received Dupixent 300 mg injection weekly or a placebo (inactive substance). A reduction in disease symptoms and trouble swallowing was seen in 24 weeks. In these patients at 24 weeks, a 69% and 64% reduction in disease...
Eosinophilic Esophagitis:DUPIXENT is indicated for the treatment of adult and pediatric patients aged 1 year and older, weighing at least 15 kg, with eosinophilic esophagitis (EoE). Prurigo Nodularis:DUPIXENT is indicated for the treatment of adult patients with prurigo nodularis (PN). ...
Ages 18+ YearsDUPIXENT is not used to relieve sudden breathing problems and will not replace an inhaled rescue medicineNOW APPROVEDAdd-on Maintenance Treatment for UncontrolledCHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSwNP)Ages 12+ YearsNow approved for ages 12+ yearsEOSINOPHILIC ESOPHAGITIS (EoE)Ages...
These diseases include approved indications for Dupixent, such as atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), eosinophilic esophagitis (EoE) and prurigo nodularis. Dupixent has received regulatory approvals in one or more countries around the world for use in...
dependent asthma; as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP), and for the treatment of adult and pediatric patients aged 12 years and older, weighing at least 40 kg, with eosinophilic esophagitis (EoE). ...